{
    "name": "polyethylene glycol & electrolytes",
    "comment": "Rx, OTC",
    "other_names": [
        "GoLytely",
        "MiraLax",
        "Glycolax",
        "GoEvac",
        "CoLav",
        "CoLyte",
        "GaviLyte-C",
        "GaviLyte-G",
        "GaviLyte-N",
        "NuLYTELY",
        "polyethylene glycol electrolyte soln",
        "polyethylene glycol powder",
        "TriLyte"
    ],
    "classes": [
        "Laxatives",
        "Osmotic",
        "Bowel Preps"
    ],
    "source": "https://reference.medscape.com/drug/golytely-miralax-polyethylene-glycol-342026",
    "pregnancy": {
        "common": [
            "Pregnancy category: C",
            "Lactation: No data available"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: No data available"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity; ileus gastrointestinal obstruction, gastric retention, toxic colitis, bowel perforation, toxic megacolon"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Osmotic laxative products may produce colonic mucosal aphthous ulcerations, including reports of more serious cases of ischemic colitis necessitating hospitalization",
                "Concomitant use of stimulant laxatives may increase risk of ischemic colitis; not recommended; consider potential for mucosal aphthous ulceration as a result of bowel preparation, especially when evaluating colonoscopy results in patients with known or suspected inflammatory bowel disease",
                "Generalized tonic-clonic seizures and/or loss of consciousness reported in patients with no prior history of seizures, which resolved with correction of fluid and electrolyte abnormalities; use caution in patients with history of seizures or who are at increased risk of seizures, including concomitant administration of medications that lower seizures threshold, patients withdrawing from alcohol or benzodiazepines, and patients with unknown or suspected hyponatremia or low serum osmolality",
                "Use with caution and observe unconscious or semiconscious patients with impaired gag reflex or other swallowing abnormalities or those who are otherwise prone to regurgitation or aspiration during administration; observe these patients during administration, especially if it is administered via nasogastric tube",
                "Avoid use in patients with bowel obstruction, megacolon, perforated bowel, ulcerative colitis, toxic colitis, gastric retention",
                "Not indicated for children <2 years because of risk of hypoglycemia, dehydration, and hypokalemia",
                "When using PEG as laxative, do not give for >1 week",
                "Electrolyte imbalance reported with prolonged use",
                "Risk of fluid and electrolyte abnormalities; electrolyte abnormalities can lead to arrhythmias, seizures, and renal impairment; patients should maintain adequate hydration before, during, and after treatment; consider post colonoscopy lab test if patient becomes dehydrated or experiences significant vomiting after treatment",
                "May cause arrhythmia; use caution with patients at risk of cardiac arrhythmia, including unstable angina, congestive heart failure, recent MI, uncontrolled arrhythmias, or cardiomyopathy; may consider pre- and post- dose ECG in patients at risk",
                "Do not combine product with starch-based thickeners; polyethylene glycol (PEG), a component of the mixture, when mixed with starch-thickened liquids, reduces viscosity of the starch-thickened liquid; when a PEG-based product used for another indication was mixed in starch-based pre-thickened liquids used in patients with dysphagia, thinning of the liquid and cases of choking and potential aspiration were reported",
                "Use caution in patients with renal impairment and/or in patients taking medications that may adversely affect renal function, including ACE inhibitors, NSAIDs, diuretics, and ARBs; instruct patients with renal impairment to remain adequately hydrated; may consider pre- and post-dose lab tests (electrolytes, creatinine, BUN) in these patients ; ensure adequate hydration, and consider laboratory testing",
                "Directly observe administration to patients at risk for aspiration",
                "Products are not for direct ingestion but require dilution with water",
                "Use caution in patients >60 years; serious adverse events reported"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Abdominal bloating",
            "percent": "50"
        },
        {
            "name": "Abdominal cramping",
            "percent": null
        },
        {
            "name": "Abdominal distention",
            "percent": null
        },
        {
            "name": "Colonic mucosal aphthous ulcerations",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Flatulence",
            "percent": null
        },
        {
            "name": "Ischemic colitis",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Cardiovascular",
            "percent": null
        },
        {
            "name": "Arrhythmia",
            "percent": null
        },
        {
            "name": "atrial fibrillation",
            "percent": null
        },
        {
            "name": "peripheral edema",
            "percent": null
        },
        {
            "name": "asystole",
            "percent": null
        },
        {
            "name": "and acute pulmonary edema after aspiration",
            "percent": null
        },
        {
            "name": "Nervous system",
            "percent": null
        },
        {
            "name": "Tremor",
            "percent": null
        },
        {
            "name": "seizure",
            "percent": null
        },
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "rash",
            "percent": null
        },
        {
            "name": "pruritus",
            "percent": null
        },
        {
            "name": "dermatitis",
            "percent": null
        },
        {
            "name": "rhinorrhea",
            "percent": null
        },
        {
            "name": "dyspnea",
            "percent": null
        },
        {
            "name": "chest and throat tightness",
            "percent": null
        },
        {
            "name": "fever",
            "percent": null
        },
        {
            "name": "angioedema",
            "percent": null
        },
        {
            "name": "anaphylaxis and anaphylactic shock",
            "percent": null
        },
        {
            "name": "Gastrointestinal",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "abdominal fullness and bloating are the most common adverse reactions",
            "percent": null
        },
        {
            "name": "occurred in up to",
            "percent": null
        },
        {
            "name": "of patients",
            "percent": null
        },
        {
            "name": "less common adverse reactions include",
            "percent": null
        },
        {
            "name": "abdominal cramps",
            "percent": null
        },
        {
            "name": "vomiting",
            "percent": null
        },
        {
            "name": "butterfly",
            "percent": null
        },
        {
            "name": "like",
            "percent": null
        },
        {
            "name": "infiltrates on chest X",
            "percent": null
        },
        {
            "name": "ray after vomiting and aspirating PEG",
            "percent": null
        },
        {
            "name": "anal irritation",
            "percent": null
        },
        {
            "name": "and upper GI bleeding from Mallory",
            "percent": null
        },
        {
            "name": "Weiss Tear",
            "percent": null
        },
        {
            "name": "esophageal perforation",
            "percent": null
        },
        {
            "name": "usually with gastroesophageal reflux disease",
            "percent": null
        },
        {
            "name": "GERD",
            "percent": null
        }
    ]
}